Phase 1 Study of ART5803 in Healthy Participants

Clinical trial NCT06575153 · COMPLETED

Trial details

NCT number: NCT06575153
Sponsor: Arialys Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Encephalitis

Start date: 2024-09-19
Primary completion: 2025-09-11
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.